Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a clinical trial, the BALANCED study, to evaluate EFX in the treatment of biopsy-confirmed NASH patients. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Akero Therapeutics Inc..
Akero Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Akero Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Akero Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Akero Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Akero Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Akero Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Akero Therapeutics Inc.- Key Facts
2.2 Akero Therapeutics Inc.- Geographic Locations
2.3 Akero Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Akero Therapeutics Inc.- Business Divisions
2.5 Akero Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Akero Therapeutics Inc. Strategic Analysis Review
3.1 Akero Therapeutics Inc.- Key Strategies
3.2 Akero Therapeutics Inc.- Company Outlook Statement
3.3 Akero Therapeutics Inc.- SWOT Analysis
3.3.1 Akero Therapeutics Inc.- Key Strengths
3.3.2 Akero Therapeutics Inc.- Key Weaknesses
3.3.3 Akero Therapeutics Inc.- Potential Opportunities
3.3.4 Akero Therapeutics Inc.- Potential Threats
3.4 Akero Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Akero Therapeutics Inc.- Business Overview
4.2 Akero Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Akero Therapeutics Inc.- Key Products
5.2 Akero Therapeutics Inc.- Key Service Areas
5.3 Akero Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Akero Therapeutics Inc.- Company History
6.2 Akero Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Akero Therapeutics Inc.- Income Statements
7.2 Akero Therapeutics Inc.- Balance Sheet
7.3 Akero Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Akero Therapeutics Inc.- Direct Competitors
8.2 Akero Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Akero Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Akero Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!